<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0149">With an emerging role for humoral immunity in chronic HBV infection control, Dr Maini suggested that it is imperative to identify and target molecular constrains of B cell immunity as part of a functional cure. It is also well established that in CHB, virus-specific T cells are depleted and functionally defective and that this exhaustion state is a key determinant of viral persistence 
 <xref rid="JVEv5-bib-0061" ref-type="bibr">[61]</xref>.
</p>
